Niraparib

CAS 1038915-60-4

Em Estoque

Niraparib

Cat. No. STUB-API-NIRAPARIBCAS 1038915-60-4Em Estoque

Dados Técnicos

Cat. No.STUB-API-NIRAPARIB

CAS1038915-60-4

Fórmula Mol.C₁₉H₂₀N₄O

Peso Mol.320.396 g/mol

IUPAC2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide

SMILESC1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N

InChIInChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1

Chave InChIPCHKPVIQAHNQLW-CQSZACIVSA-N

Pureza—

Descrição

Visão geral

Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is taken by mouth. It is a PARP inhibitor

A Anant Labs fabrica e fornece impurezas de Niraparib de alta qualidade para o mercado global. Nossas impurezas EP de Niraparib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Sinônimos

Niraparib1038915-60-4MK48272-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamideHMC2H89N35ZL-2306JNJ-64091742CHEBI:176844DTXSID50146129

Buscar APIs A–Z